Medical Drugs Services In Europe

Employing our Liver-on-a-chip hepatic co-culture model (evaluated by our collaborators at the U.S. FDA), our DILI in vitro Service can screen your small molecules, antibodies, ASO, and gene editing reagents to establish human DILI ...

Whatever the protein you wish to express, you need an optimal cell line, high yielding and stable. You are looking for an experienced specialist with a proven track record in developing cell lines even for challenging proteins – regulatory accepted, fast, reliable. You found ...

The analysis of repertoire sequencing (Rep-Seq) data is not straightforward and requires the integration of various disciplines, including immunology, bioinformatics, statistics and software engineering. The ENPICOM team harbors the knowledge and expertise in all relevant research areas required to tackle the complexity of immune repertoire sequencing data. We perform data analysis service from ...

Ipsen’s commitment to research & development is our bold promise to patients to launch at least one new drug or meaningful new indication every year. We will secure our future by building a pipeline of innovative medicines, establishing our leadership position in key therapeutic areas, ensuring sustainable lifecycle management and, most importantly, creating a company of inspiring ...

Small molecule inhibitors are a class of small molecules that interact with proteins and reduce the biological activity of target proteins. The structure of small molecule inhibitors has good spatial dispersion, and their chemical properties determine their good pharmacodinemic properties and pharmacokinetic properties. These characteristics make small molecule inhibitors show great advantages in ...

Our goal is to deliver the tools to accelerate drug development through these stages together with all the scientists over the world towards patient’s benefit. Our experienced team with long-standing expertise in Multi-Organ-Chip assay development (>50 MOC publications) will design your flexible, efficient and reliable assay for safety or efficacy ...

Biovian is a One-Stop-Shop CDMO for bacterial and yeast-based production of Drug Substances and Drug Products. Our microbial production services include GMP production of recombinant proteins and plasmid DNA for vaccines. The microbial GMP-manufacturing unit of Biovian is equipped with state-of-the-art fermenters, harvesting equipment, and a choice of downstream purification capabilities. ...

Aiming at optimizing your clinical development strategy, our expert consultants develop the innovative strategies and capabilities needed to launch products with the greatest potential for commercial success and improved patient outcomes. ...

At Catalent, our methodologies work toward reducing the overall costs and time it takes to get your product to the clinic. With decades of experience in analytical development, we understand our clients’ needs, the current regulatory environment, and have a history of the development and qualification of analytical methods. We operate with a forward-looking methodology by deploying robust ...

Increasingly, data are transforming our understanding of diseases. This is especially true in cancer. We have invested in robust data science capabilities to enable rapid data-driven decision making as we advance our products through all stages of development. Integration of disparate data sets from clinical and pre-clinical studies is a major guiding principle that is allowing us to extract ...

Enzymes are macromolecules with biocatalytic function to accelerate chemical reactions. Enzymes are indispensable in various functions of living organisms and play key roles in almost every physiological/pathological process such as signal transduction, cell regulation, metabolism, activity control and digestion. Strict control of enzyme activity is essential for homeostasis. Any malfunction of ...

WOM represents innovation in Minimally Invasive Medicine. Accordingly, our teams stand out when it comes to the assembly of medical devices and cleanroom production due to their vast amount of ...

Advanced scientific platform for drug delivery, pre-clinical and clinical development. Team of 10+ scientists, deploying optimized proprietary methodologies in extraction, formulation development, analytical testing, pre-clinical models, and clinical development. Comprehensive IP portfolio across all platforms that has led to the development of 20+ proprietary commercial products. R&D ...

Knowledge is the basis for the successful realization of GMP requirements 'Knowledge without experience is only a dead load' (Mosché Feldenkrais) Take advantage of our knowledge and our long years of ...

Adapted to individual targets, individual requirements and the scope of the ...

Over the last decade, high-throughput screening assays have produced thousands of candidate drugs with potential efficacy in pharmacological activity. However, a majority of these drugs have failed during drug development for reasons related to ...

Drug abuse liability is the potential that a drug has properties that facilitate people becoming addicted or dependent on it. This phenomenon may be caused by drugs' pharmacological and psychopharmacological properties or social aspects around their self-administration. The addictive potency of drugs varies between different drugs. For instance, drugs such as heroin or cocaine have higher abuse ...

Since 2002, clients from the United States, Europe and all over the world have trusted our Good Manufacturing Practice (GMP) to produce their antibodies and recombinant proteins for clinical use. Our goal is to grow with clients towards commercial manufacturing. Working in a competitive time-frame, we are committed to nothing less than your success. The long-standing experience of our expert team ...

Our commitment to R&D allows us to help companies be cost-effective and efficient when fill-finishing their parenteral products in prefilled drug delivery ...

The CSR product line leads the industry with bioreactor volumes up to 6,000L Vw, fermenter volumes up to 1,000L Vw, and liquid mixing systems up to 7,000L Vw, delivering significantly more capacity per unit area of floor space; a key metric in high-value multi-product biopharmaceutical facilities. ...